Advanced Oncotherapy plc (LON:AVO – Get Rating)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 32.04 ($0.42) and traded as low as GBX 22.75 ($0.30). Advanced Oncotherapy shares last traded at GBX 23 ($0.30), with a volume of 374,105 shares traded.
The stock’s 50-day simple moving average is GBX 25.08 and its 200-day simple moving average is GBX 32.04. The stock has a market cap of £106.54 million and a price-to-earnings ratio of -2.61. The company has a current ratio of 0.91, a quick ratio of 0.08 and a debt-to-equity ratio of 161.92.
In other news, insider Enrico Cipro Vanni purchased 100,000 shares of the business’s stock in a transaction dated Wednesday, March 2nd. The stock was bought at an average price of GBX 26 ($0.34) per share, with a total value of £26,000 ($33,827.74).
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, selling, and maintaining proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Further Reading
- 3 Resilient Stocks to Buy for Retirement
- MarketBeat: Week in Review 4/18 – 4/22
- Tractor Supply Company Reaps What It Sows
- Snap (NYSE: SNAP) Gives Investors A Mixed Bag
- Should You Buy Carvana or AutoNation or Pass on Both?
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
